Duvyzat (givinostat) is an FDA approved medication used to treat Duchenne Muscular Dystrophy (DMD) in people ages 6 years and older, regardless of the type of genetic mutation (change) they have. This medication doesn’t contain a steroid and isn’t an injection. Instead, it’s available as a liquid solution that’s taken 2 times a day by mouth. Common side effects are diarrhea, nausea, and stomach pain. During treatment, you’ll work with your child's care team to regularly check labs, such as blood counts and triglyceride levels. These tests are important because they help monitor for potential issues that could lead to side effects, like excessive bleeding.
Duvyzat (givinostat) is a histone deacetylase inhibitor, which means it blocks a protein called histone deacetylase from working. People with DMD are thought to have higher histone deacetylase activity in their weakening muscles. By blocking these proteins, Duvyzat (givinostat) helps muscles rebuild and reduces inflammation.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Contact your healthcare provider immediately if you experience any of the following.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
Duchenne Muscular Dystrophy is a genetic condition passed from parent to child that causes muscle damage and muscle weakness over time. This condition affects more boys compared to girls. Symptoms begin to show up between ages 2 and 3 years old. Common signs and symptoms are toe walking, difficult running and falling down. This condition continues to get worse over time but can be treated with Duvyzat (givinostat) to slow down the muscle loss over time.
Duvyzat (givinostat) is only approved to slow muscle loss in DMD for people ages 6 years and older. Since children are typically diagnosed with DMD around 2-5 years old, this medication might not be an option right away. Instead, steroids are usually started as a first-choice treatment to slow muscle breakdown. Duvyzat (givinostat) is approved to treat all types of DMD, which can be caused by different genetic changes (or mutations). Other approved medications, like Vyondys 53 (golodirsen), only work for people with a specific genetic mutation. Talk to your prescriber to see if Duvyzat (givinostat) is right for your child.
Shake the bottle of Duvyzat (givinostat) and measure the correct dose with the provided syringe. Make your child sit upright and place the top of the syringe against the inside of their cheek. Push the plunger of the syringe slowly until all the medication is out. If your child’s dose is more than 5mL, measure the remainder of the medication and do the same steps again.
No. Duvyzat (givinostat) is a histone deacetylase blocker. This medication doesn’t contain any steroid components. Other DMD medications, like Emflaza (deflazacort), are steroids which is typically a first-choice treatment for DMD. Because Duvyzat (givinostat) is pretty new, it isn’t listed on the current guidelines for treatment of DMD yet. This can be discussed with your child's prescriber to determine if this medication is appropriate.
No. Duvyzat (givinostat) doesn’t cure Duchenne Muscular Dystrophy. Duvyzat (givinostat) is a medication that helps restore muscle and prevent muscle loss. Currently, there isn’t a cure for DMD. But Duvyzat (givinostat) helps to slow the worsening of DMD. If you have any questions about whether this medication is appropriate for your child, reach out to their prescriber.
Duvyzat (givinostat) works to slow down muscle damage over time. A study involving young boys with DMD compared results of a 4 stair climb between a group that received Duvyzat (givinostat) with corticosteroids with a group that took corticosteroids with a placebo. Boys in both treatment groups receive corticosteroids as this is a typical first-choice treatment in children with DMD. The study measured how quickly the boys could climb 4 stairs, both before starting treatment and again 18 months later. At the end of the study both groups showed worsening in their ability to climb the 4 stairs. But, the group of boys that received Duvyzat (givinostat) had a slower decline compared to the group that only received corticosteroids.
Answers: If your child is experiencing severe diarrhea or nausea and vomiting, contact your child’s care team. It’s important to make sure that your child is drinking plenty of fluids to avoid dehydration. Start giving smaller meals throughout the day. Slowly give more fiber rich foods like oats, broccoli, and whole grains. If appropriate, there are certain medications your child’s care team may suggest for diarrhea or nausea and vomiting. Depending on how serious the side effects are, your child’s prescriber may also adjust the dose for Duvyzat (givinostat) or recommend stopping the medication altogether.
Duvyzat (givinostat) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Taking Duvyzat (givinostat) can cause lower blood cell counts, particularly lower platelet levels. These levels drop to their lowest during the first two months of treatment, and continue to stay low as long as your child takes this medication. This is why your child will have their labs drawn every two weeks for the first 2 months, then monthly for the next 3 months, and eventually every 3 months after that while continuing treatment. These labs are important to make sure that the dose of Duvyzat (givinostat) continues to be safe for your child. Labs are completed to catch low platelet counts before they get dangerously low, which can lead to issues such as bleeding or increased risk for infections.
If your child has lower platelet counts, their prescriber may lower the dose of Duvyzat (givinostat) or temporarily stop the medication. If it still doesn’t get better, your child may have to stop taking the medication permanently. Be sure to look out for symptoms and contact your child’s prescriber if they experience unusual bruising, nosebleeds, or any type of excessive bleeding.
Taking Duvyzat (givinostat) can raise fat levels in the blood. Having high triglycerides levels over time can increase the chances of heart disease. Your child should get their triglyceride labs checked during their 1st month, 3rd month, and 6th month of starting treatment, and then every 6 months after that. Because there usually aren’t any symptoms with having high triglycerides, it’s important for your child to go to their lab appointments. If your child has high triglycerides, their care team might lower their Duvyzat (givinostat) dose. A balanced diet with bland proteins, carbs, healthy fats, and fiber is important for people with DMD and can help keep triglycerides low.
Diarrhea, nausea, and vomiting are common side effects of Duvyzat (givinostat). Children are more likely to experience diarrhea within the first few weeks of treatment, and nausea and vomiting within the first 2 months of treatment. Contact your child’s care team if they have severe diarrhea, nausea, or vomiting after taking Duvyzat (givinostat). Your child’s care team may recommend other medications, such as ondansetron (Zofran) or loperamide (Imodium A-D), that can help ease symptoms If symptoms become severe, your child’s prescriber might suggest reducing the dose or stopping the medication. It’s also important to make sure that your child is getting enough fluids to prevent dehydration. At home you can help by providing smaller meals throughout the day which may help relieve symptoms.
Duvyzat (givinostat) can cause a potentially life-threatening abnormal heart rhythm known as QT prolongation. Your child might need an electrocardiogram (ECG or EKG) before starting the medication if they have a history of heart problems or are taking another medication that may cause QT prolongation. Sometimes QT prolongation doesn’t cause any noticeable symptoms unless it becomes more serious. Serious symptoms may include heart pounding, unusual dizziness, or passing out. It’s important to contact your child's care team right away if they experience any of those symptoms as Duvyzat (givinostat) may need to be stopped.
| Dosage | Quantity | Price as low as | Price per unit |
|---|---|---|---|
| 140ml of 8.86mg/ml | 1 bottle | $36,769.47 | $36,769.47 |
Duvyzat (givinostat) is approved for people ages 6 years and older.
Duvyzat (givinostat) comes as an oral solution that contains 8.86 mg per mL.
Your child's dose will depend on their weight:
The dose might be different if your child is experiencing side effects like severe diarrhea, low blood counts, and high triglycerides levels in the blood.